Little Green Pharma (LGP) has already recovered its investment in Health House, with the distribution business posting A$800,000 in sales during the two months following the acquisition.
LGP purchased Health House from Melodiol Global Health earlier this year for $375,000 in cash, taking on an estimated $350,000 in liabilities as part of the deal.
The company said the integration of Health House was "currently underway and ahead of schedule" with the majority of its customers retained.
LGP said the acquisition supports its vertical integration strategy as the broader industry continues to consolidate.
The deal was widely seen as a bargain in February, given that LGP had originally agreed to a $1.25m cash transaction for Health House back in November 2024. Melodiol had previously sought $10.9m when it put the business on the market.
The swift return on the investment contributed to unaudited revenue growth of 40% in FY25, bringing total revenue to $36.6m. The final quarter generated $9.6m — an increase of more than 30% on the same period the prior year — with a record $4m of that figure coming in March alone.
LGP has also renewed its loan facilities with NAB through to June 30, 2027, and closed out the year with $2.4m in cash on hand.
